Frequently Asked Questions (FAQs)
Research & Handling
General Questions
Most of our research compounds, including our 5mg and 10mg vials, are supplied as lyophilized (freeze-dried) powders. This ensures stability during shipping and storage. Researchers will need to reconstitute them with an appropriate solvent, such as Bacteriostatic Water (BAC Water), prior to experimental use.
We prioritize research integrity. Our peptides, such as GHK-Cu and BPC-157, undergo rigorous testing, including High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS), to ensure high purity (typically >99%). Certificates of Analysis (CoA) are available upon request for verification.
No. We are a chemical supplier, not a medical clinic. We cannot and do not provide instructions on "dosing," "injection," or "usage" for human subjects. Any communication suggesting human use may result in the cancellation of your order and the termination of your account. Please refer to published scientific literature for experimental concentration guidelines.
All products listed in our catalog, including GLP-3(R) and SM-GLP1, are sold strictly for laboratory research purposes only. They are intended for in vitro experiments, binding assays, and analytical testing. They are not for human or animal consumption, therapeutic use, or diagnostic purposes.
Lyophilized peptides are stable at room temperature for short periods during shipping. However, for long-term storage and to maintain maximum stability, we recommend storing vials in a freezer at -20°C (-4°F).
Once reconstituted, the stability of research solutions varies by compound. Generally, we recommend storing reconstituted peptides at 4°C (39°F) and using them within 2-4 weeks. Researchers should avoid repeated freeze-thaw cycles, as this can degrade the peptide structure.
GLP-1 / GLP-2 / GLP-3 Peptides
GLP-1 (Glucagon-Like Peptide-1) is a naturally occurring incretin hormone studied for its role in glucose-dependent insulin secretion, appetite regulation, and gastric motility. In research settings, GLP-1 peptide analogs are used in in vitro receptor binding assays, metabolic signaling studies, and preclinical models of glycemic regulation. All Dallas Biochemical Supply GLP-1 peptides are supplied as lyophilized research compounds verified by HPLC and mass spectrometry.
GLP-1 (Glucagon-Like Peptide-1) primarily targets pancreatic beta cells and appetite-regulating neurons. GLP-2 (Glucagon-Like Peptide-2) is studied for its role in intestinal epithelial growth and gut integrity. GLP-3, or GLP-3(R), is a proprietary research compound that builds upon the GLP pathway with multi-receptor activity. These are distinct molecular compounds with different receptor profiles and research applications. All are intended strictly for laboratory in vitro research use only.
SM-GLP1 is a structural modification of the GLP-1 peptide designed to study extended receptor engagement in research models. While standard GLP-1 has a short half-life due to rapid DPP-4 enzyme degradation, structural analogs like SM-GLP1 are modified to resist enzymatic cleavage — making them useful in longer-duration in vitro studies of GLP-1 receptor signaling.
GLP-2 (Glucagon-Like Peptide-2) is a 33-amino acid peptide studied for its trophic effects on intestinal epithelium. Research applications include in vitro models of intestinal barrier function, mucosal repair, and enteroendocrine signaling. It is not for human or animal use — all GLP-2 compounds are supplied as lyophilized research reagents for analytical investigation only.
Retatrutide
Retatrutide is a triple-receptor agonist peptide that simultaneously targets GLP-1, GIP (Glucose-Dependent Insulinotropic Polypeptide), and glucagon receptors. This multi-pathway mechanism distinguishes it from single-agonist peptides like Semaglutide (GLP-1 only) or dual-agonists like Tirzepatide (GLP-1 + GIP). In preclinical and early-phase research, Retatrutide has been investigated for its effects on metabolic energy balance, appetite modulation, and lipid metabolism. Dallas Biochemical Supply's Retatrutide is supplied lyophilized with full COA documentation.
Semaglutide acts on the GLP-1 receptor only. Tirzepatide is a dual agonist targeting GLP-1 and GIP. Retatrutide adds glucagon receptor activity to those two pathways, creating a triple-receptor research compound. Early research suggests this triple-agonist approach may produce broader effects on energy expenditure and fat metabolism. These comparisons are strictly for in vitro and preclinical research contexts — none of these compounds are approved for human use.
Yes. Dallas Biochemical Supply provides Retatrutide as a lyophilized powder in research vials. It must be reconstituted with Bacteriostatic Water (BAC Water) prior to experimental use and handled according to proper peptide research protocols.
Wolverine Stack
The "Wolverine Stack" refers to the research peptide combination of BPC-157 (Body Protection Compound-157) and TB-500 (a synthetic analog of Thymosin Beta-4). In preclinical research models, BPC-157 has been studied for localized tissue repair effects, while TB-500 is investigated for systemic cellular migration and angiogenesis support. Together, these peptides are studied for their potential synergistic effects on musculoskeletal and connective tissue models. All compounds are for in vitro/laboratory research use only.
BPC-157 is a pentadecapeptide (15 amino acids) derived from a gastric protein sequence, primarily studied for localized effects on tendon, ligament, muscle, and GI tissue in preclinical models. TB-500 is a synthetic analog of Thymosin Beta-4, studied for more systemic effects including cellular migration, angiogenesis, and anti-inflammatory activity. Researchers often study them together due to their potentially complementary mechanisms of action.
Yes. BPC-157 and TB-500 are available individually through our catalog, as well as in pre-blended research configurations. All are supplied lyophilized at ≥99% purity, third-party tested via HPLC and mass spectrometry, and accompanied by a Certificate of Analysis (COA).
Glow Blend
The "Glow" blend is a multi-peptide research formulation combining GHK-Cu, BPC-157, and TB-500 — three compounds studied for synergistic effects in dermal regeneration, collagen synthesis, wound healing, and tissue repair models. GHK-Cu contributes regenerative and gene-modulatory properties, TB-500 supports cellular migration and angiogenesis, and BPC-157 adds anti-inflammatory and tissue-stabilizing activity. The Glow blend is designed for research use in skin biology, dermatology models, and regenerative science.
GHK-Cu is a single copper-binding tripeptide (Glycyl-L-Histidyl-L-Lysine + Cu²⁺) studied extensively on its own for collagen synthesis, gene expression modulation, and anti-inflammatory activity. The Glow blend is a multi-peptide formulation that includes GHK-Cu as its foundational compound, combined with BPC-157 and TB-500 to create a broader tissue regeneration research profile. Researchers focused exclusively on GHK-Cu mechanisms may prefer the single compound, while those studying multi-pathway dermal or tissue models may find the Glow blend more appropriate.
Yes. The Glow blend's peptide profile — led by GHK-Cu, with BPC-157 and TB-500 — has been studied in preclinical skin models for effects on dermal remodeling, wound closure, oxidative stress reduction, and barrier restoration. It is available as a lyophilized research compound at ≥99% purity. It is not a cosmetic product and is not intended for topical human use.
GHK-Cu
GHK-Cu (Glycyl-L-Histidyl-L-Lysine Copper Complex) is a naturally occurring tripeptide that binds copper(II) ions. It has been one of the most studied regenerative peptides in dermatological and cellular biology research. Key areas of investigation include collagen and elastin synthesis, gene expression modulation (studies have noted influence on expression of approximately 4,000 human genes), wound healing, anti-inflammatory signaling, and angiogenesis. It is supplied by Dallas Biochemical Supply as a lyophilized research compound verified at ≥99% purity.
Yes — this is a critical distinction. GHK is the raw tripeptide (Glycyl-L-Histidyl-L-Lysine) without a metal ion. GHK-Cu is the biologically active complex formed when the GHK tripeptide binds a copper(II) (Cu²⁺) ion. The vast majority of the regenerative, anti-inflammatory, and gene-modulating research data is specific to the GHK-Cu form. Dallas Biochemical Supply supplies the fully complexed GHK-Cu peptide, not the uncomplexed GHK tripeptide.
GHK-Cu should be stored lyophilized at -20°C in a frost-free environment, protected from light and humidity. Once reconstituted with Bacteriostatic Water (BAC Water), the solution should be stored at 2–8°C and used within the timeframe appropriate for your research protocol. Avoid repeated freeze-thaw cycles of the reconstituted solution, as this may compromise peptide integrity.
For most research applications, GHK-Cu is reconstituted with sterile Bacteriostatic Water (BAC Water). Some protocols may call for a dilute acetic acid solution (0.1%–1%) depending on solubility requirements for the specific experimental assay. Researchers should consult solubility data included with the COA and follow institutional laboratory protocols for handling.
General Peptide Research
Yes. Every peptide compound offered by Dallas Biochemical Supply — including GHK-Cu, GLP-1, GLP-3(R), Retatrutide, BPC-157, TB-500, and all blended formulations — is verified through independent third-party HPLC and mass spectrometry testing. COA documentation is available upon request and confirms amino acid sequence accuracy, purity levels ≥99%, and lot-specific quality data.
No. All products sold by Dallas Biochemical Supply are strictly for laboratory research and analytical use only. None of the compounds — including Retatrutide, GHK-Cu, GLP-1 analogs, GLP-3(R), the Glow blend, or the Wolverine Stack peptides — are approved by the FDA for human or veterinary use, and they are not intended to diagnose, treat, cure, or prevent any disease. Any indication of intended human use will result in immediate order cancellation and permanent account termination.
For most research applications, GHK-Cu is reconstituted with sterile Bacteriostatic Water (BAC Water). Some protocols may call for a dilute acetic acid solution (0.1%–1%) depending on solubility requirements for the specific experimental assay. Researchers should consult solubility data included with the COA and follow institutional laboratory protocols for handling.